IntroductionThe North West London Hospitals NHS Trust (NWLHT) Formulary is a list of medicines approved for local prescribing. Medicines are listed alphabetically by generic name and under the Bristish National Formulary (BNF) chapter headings.
Please note: The formulary does not specify the brand name or formulation of a medicine as these may vary depending on contracts or the needs of an individual patient. Some of the medicines are approved for use only within certain treatment pathway.
The Formulary is not fully complete for some unlicensed medicines.
If you have any questions about the NWLHT formulary, please contact the Medicine Information department on: 020 8869 2761/ 2762 (Mon to Fri 9am– 5pm).
1.1 Dyspepsia and gastro-oesophageal reflux disease
1.2 Antispasmodics and other drugs altering gut motility
1.3 Antisecretory drugs and mucosal protectants
1.9 Drugs affecting intestinal secretions
1.2 Antispasmodics and other drugs altering gut motility
1.3 Antisecretory drugs and mucosal protectants
1.2 Antispasmodics and other drugs altering gut motility
1.3 Antisecretory drugs and mucosal protectants
1.1 Dyspepsia and gastro-oesophageal reflux disease
1.2 Antispasmodics and other drugs altering gut motility
1.3 Antisecretory drugs and mucosal protectants
1.7 Local preparations for anal and rectal disorders
1.3 Antisecretory drugs and mucosal protectants
1.9 Drugs affecting intestinal secretions
1.3 Antisecretory drugs and mucosal protectants
1.2 Antispasmodics and other drugs altering gut motility
1.7 Local preparations for anal and rectal disorders
1.2 Antispasmodics and other drugs altering gut motility
1.3 Antisecretory drugs and mucosal protectants
1.3 Antisecretory drugs and mucosal protectants
1.3 Antisecretory drugs and mucosal protectants
1.3 Antisecretory drugs and mucosal protectants
1.9 Drugs affecting intestinal secretions
2.10 Stable angina, acute coronary syndromes, and fibrinolysis
2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
2.11 Antifibrinolytic drugs and haemostatics
2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
2.10 Stable angina, acute coronary syndromes, and fibrinolysis
2.10 Stable angina, acute coronary syndromes, and fibrinolysis
2.11 Antifibrinolytic drugs and haemostatics
2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
3.4 Antihistamines, hyposensitisation, and allergic emergencies
3.4 Antihistamines, hyposensitisation, and allergic emergencies
3.4 Antihistamines, hyposensitisation, and allergic emergencies
3.4 Antihistamines, hyposensitisation, and allergic emergencies
3.4 Antihistamines, hyposensitisation, and allergic emergencies
3.3 Cromoglicate and related therapy, leukotriene receptor antagonists, and phosphodiesterase type-4 inhibitors
3.4 Antihistamines, hyposensitisation, and allergic emergencies
3.5 Respiratory stimulants and pulmonary surfactants
3.4 Antihistamines, hyposensitisation, and allergic emergencies
3.3 Cromoglicate and related therapy, leukotriene receptor antagonists, and phosphodiesterase type-4 inhibitors
3.3 Cromoglicate and related therapy, leukotriene receptor antagonists, and phosphodiesterase type-4 inhibitors
4.9 Drugs used in parkinsonism and related disorders
4.2 Drugs used in psychoses and related disorders
4.9 Drugs used in parkinsonism and related disorders
4.2 Drugs used in psychoses and related disorders
4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder
4.2 Drugs used in psychoses and related disorders
4.9 Drugs used in parkinsonism and related disorders
4.9 Drugs used in parkinsonism and related disorders
4.9 Drugs used in parkinsonism and related disorders
4.9 Drugs used in parkinsonism and related disorders
4.2 Drugs used in psychoses and related disorders
4.2 Drugs used in psychoses and related disorders
4.9 Drugs used in parkinsonism and related disorders
4.9 Drugs used in parkinsonism and related disorders
4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder
4.9 Drugs used in parkinsonism and related disorders
4.2 Drugs used in psychoses and related disorders
4.2 Drugs used in psychoses and related disorders
4.2 Drugs used in psychoses and related disorders
4.2 Drugs used in psychoses and related disorders
4.2 Drugs used in psychoses and related disorders
4.2 Drugs used in psychoses and related disorders
4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder
4.2 Drugs used in psychoses and related disorders
4.2 Drugs used in psychoses and related disorders
4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder
4.2 Drugs used in psychoses and related disorders
4.5 Drugs used in the treatment of obesity
4.9 Drugs used in parkinsonism and related disorders
4.9 Drugs used in parkinsonism and related disorders
4.2 Drugs used in psychoses and related disorders
4.2 Drugs used in psychoses and related disorders
4.9 Drugs used in parkinsonism and related disorders
4.2 Drugs used in psychoses and related disorders
4.9 Drugs used in parkinsonism and related disorders
4.2 Drugs used in psychoses and related disorders
4.2 Drugs used in psychoses and related disorders
4.9 Drugs used in parkinsonism and related disorders
4.2 Drugs used in psychoses and related disorders
4.9 Drugs used in parkinsonism and related disorders
4.9 Drugs used in parkinsonism and related disorders
4.2 Drugs used in psychoses and related disorders
4.9 Drugs used in parkinsonism and related disorders
4.9 Drugs used in parkinsonism and related disorders
4.2 Drugs used in psychoses and related disorders
4.9 Drugs used in parkinsonism and related disorders
4.2 Drugs used in psychoses and related disorders
4.2 Drugs used in psychoses and related disorders
4.2 Drugs used in psychoses and related disorders
See Trust's approved ANTIMICROBIAL guidelines
6.5 Hypothalamic and pituitary hormones and anti-oestrogens
6.5 Hypothalamic and pituitary hormones and anti-oestrogens
6.5 Hypothalamic and pituitary hormones and anti-oestrogens
6.5 Hypothalamic and pituitary hormones and anti-oestrogens
6.5 Hypothalamic and pituitary hormones and anti-oestrogens
6.5 Hypothalamic and pituitary hormones and anti-oestrogens
6.5 Hypothalamic and pituitary hormones and anti-oestrogens
6.5 Hypothalamic and pituitary hormones and anti-oestrogens
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
COMBINED HORMONAL CONTRACEPTIVES 07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
Ethinylestradiol with cyproterone acetate
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
7.2 Treatment of vaginal and vulval conditions
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
7.2 Treatment of vaginal and vulval conditions
07 Obstetrics, gynaecology, and urinary-tract disorders
7.2 Treatment of vaginal and vulval conditions
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
07 Obstetrics, gynaecology, and urinary-tract disorders
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
8.3 Sex hormones and hormone antagonists in malignant disease
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
8.3 Sex hormones and hormone antagonists in malignant disease
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
8.3 Sex hormones and hormone antagonists in malignant disease
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
8.3 Sex hormones and hormone antagonists in malignant disease
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
8.3 Sex hormones and hormone antagonists in malignant disease
08 Malignant disease and immunosuppression
8.3 Sex hormones and hormone antagonists in malignant disease
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
8.3 Sex hormones and hormone antagonists in malignant disease
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
8.3 Sex hormones and hormone antagonists in malignant disease
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
8.3 Sex hormones and hormone antagonists in malignant disease
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
8.3 Sex hormones and hormone antagonists in malignant disease
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
8.3 Sex hormones and hormone antagonists in malignant disease
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
8.3 Sex hormones and hormone antagonists in malignant disease
08 Malignant disease and immunosuppression
8.3 Sex hormones and hormone antagonists in malignant disease
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
8.3 Sex hormones and hormone antagonists in malignant disease
08 Malignant disease and immunosuppression
8.3 Sex hormones and hormone antagonists in malignant disease
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
8.3 Sex hormones and hormone antagonists in malignant disease
08 Malignant disease and immunosuppression
8.3 Sex hormones and hormone antagonists in malignant disease
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
8.3 Sex hormones and hormone antagonists in malignant disease
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
8.3 Sex hormones and hormone antagonists in malignant disease
08 Malignant disease and immunosuppression
8.3 Sex hormones and hormone antagonists in malignant disease
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
08 Malignant disease and immunosuppression
9.1 Anaemias and some other blood disorders
9.1 Anaemias and some other blood disorders
9.1 Anaemias and some other blood disorders
9.1 Anaemias and some other blood disorders
9.1 Anaemias and some other blood disorders
9.1 Anaemias and some other blood disorders
9.1 Anaemias and some other blood disorders
9.1 Anaemias and some other blood disorders
9.1 Anaemias and some other blood disorders
9.1 Anaemias and some other blood disorders
9.1 Anaemias and some other blood disorders
9.1 Anaemias and some other blood disorders
9.1 Anaemias and some other blood disorders
9.1 Anaemias and some other blood disorders
9.1 Anaemias and some other blood disorders
9.1 Anaemias and some other blood disorders
9.1 Anaemias and some other blood disorders
9.1 Anaemias and some other blood disorders
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.2 Drugs used in neuromuscular disorders
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.2 Drugs used in neuromuscular disorders
10.2 Drugs used in neuromuscular disorders
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.2 Drugs used in neuromuscular disorders
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.3 Drugs for the treatment of soft-tissue disorders and topical pain relief
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.2 Drugs used in neuromuscular disorders
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.2 Drugs used in neuromuscular disorders
10.2 Drugs used in neuromuscular disorders
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.1 Drugs used in rheumatic diseases and gout
10.2 Drugs used in neuromuscular disorders
11.8 Miscellaneous ophthalmic preparations
11.4 Corticosteroids and other anti-inflammatory preparations
11.8 Miscellaneous ophthalmic preparations
11.4 Corticosteroids and other anti-inflammatory preparations
11.8 Miscellaneous ophthalmic preparations
11.8 Miscellaneous ophthalmic preparations
11.4 Corticosteroids and other anti-inflammatory preparations
11.4 Corticosteroids and other anti-inflammatory preparations
11.8 Miscellaneous ophthalmic preparations
11.4 Corticosteroids and other anti-inflammatory preparations
11.8 Miscellaneous ophthalmic preparations
11.4 Corticosteroids and other anti-inflammatory preparations
11.8 Miscellaneous ophthalmic preparations
11.8 Miscellaneous ophthalmic preparations
11.8 Miscellaneous ophthalmic preparations
11.8 Miscellaneous ophthalmic preparations
11.4 Corticosteroids and other anti-inflammatory preparations
11.4 Corticosteroids and other anti-inflammatory preparations
11.4 Corticosteroids and other anti-inflammatory preparations
11.4 Corticosteroids and other anti-inflammatory preparations
11.8 Miscellaneous ophthalmic preparations
11.8 Miscellaneous ophthalmic preparations
11.4 Corticosteroids and other anti-inflammatory preparations
11.8 Miscellaneous ophthalmic preparations
11.4 Corticosteroids and other anti-inflammatory preparations
11.8 Miscellaneous ophthalmic preparations
11.4 Corticosteroids and other anti-inflammatory preparations
11.8 Miscellaneous ophthalmic preparations
13.5 Preparations for eczema and psoriasis
13.5 Preparations for eczema and psoriasis
13.3 Topical local anaesthetics and antipruritics
13.5 Preparations for eczema and psoriasis
13.5 Preparations for eczema and psoriasis
13.11 Skin cleansers, antiseptics, and desloughing agents
13.11 Skin cleansers, antiseptics, and desloughing agents
13.5 Preparations for eczema and psoriasis
13.3 Topical local anaesthetics and antipruritics
13.5 Preparations for eczema and psoriasis
13.3 Topical local anaesthetics and antipruritics
13.11 Skin cleansers, antiseptics, and desloughing agents
13.5 Preparations for eczema and psoriasis
13.5 Preparations for eczema and psoriasis
13.11 Skin cleansers, antiseptics, and desloughing agents
13.11 Skin cleansers, antiseptics, and desloughing agents
13.5 Preparations for eczema and psoriasis
13.11 Skin cleansers, antiseptics, and desloughing agents
13.5 Preparations for eczema and psoriasis
13.5 Preparations for eczema and psoriasis
13.5 Preparations for eczema and psoriasis
13.5 Preparations for eczema and psoriasis
13.5 Preparations for eczema and psoriasis
13.5 Preparations for eczema and psoriasis
2001, 34, 77–80 EVALUATION OF AN AWARENESS ENHANCEMENT JASON M. STRICKER, RAYMOND G. MILTENBERGER,MATTHEW A. GARLINGHOUSE, CRISTINE M. DEAVER, ANDAn evaluation of the awareness enhancement device (AED) described by Rapp, Milten-berger, and Long (1998) was conducted with 2 children who engaged in thumb suckingpast the age at which it was developmentally appropriate. The AED effectively sup
1836 State Street, Santa Barbara, CA 93101; PO Box 90106, Santa Barbara, CA 93190; Telephone (805) 965-7570; fax (805) 962-0651 Jeanine Townsend, Clerk to the Board State Water Resources Control Board 1001 I Street, 24th Floor Sacramento, CA 95814 Re: Proposed Amendment to the Recycled Water Policy to Incorporate Monitoring Requirements for Constituents of Emerging Concern Dea